Lv1
100 积分 2025-10-28 加入
OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours
3个月前
已完结
Optimizing In Vivo CAR-T Cell Engineering for Cancer Immunotherapy
4个月前
已完结
Mannose metabolism reshapes T cell differentiation to enhance anti-tumor immunity
5个月前
已完结
Exosomes as nonviral carrier for targeted delivery of CRISPR-Cas12a for therapeutic HIV-1 proviral DNA editing
6个月前
已完结
Improving Lentiviral Transduction of Human Adipose-Derived Mesenchymal Stem Cells
6个月前
已完结
DR5 CAR-NK Cells Demonstrate Superior Scalability and Potent Antitumor Activity with Favorable Safety
7个月前
已完结
DR5 CAR-NK Cells Demonstrate Superior Scalability and Potent Antitumor Activity with Favorable Safety
7个月前
已完结
DR5 CAR-NK Cells Demonstrate Superior Scalability and Potent Antitumor Activity with Favorable Safety
7个月前
已完结
皖公网安备34019202002308
